Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

SCHEDULE B

FORM OF LETTER OF RESIGNATION
 
To:
Cell Cure Neurosciences Ltd. (the “Company”)

Re:
Resignation from the Board of Directors
 
I, undersigned, hereby resign from the Board of Directors of the Company subject to and effective as of immediately following the Closing of the Share Purchase and Transfer Agreement by and among BioTime, Inc., HBL-Hadasit Bio-Holdings Ltd., and the Company, dated June 16, 2017 (the “SPA”). Capitalized terms used herein and not defined herin shall have the meaning ascribed to them in the SPA.

 
 
Baruch Halpert
 
 
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
15

© Copyright BioTime, Inc.